Calu-3

Summary

Calu-3 is a cell line^[1].

Key Facts

• Calu-3's image is recorded as Trastuzumab Fab-HER2 complex 1N8Z.png^[2].
• Calu-3's instance of is recorded as cell line^[3].
• Calu-3's instance of is recorded as cancer cell line^[4].
• Calu-3's described by source is recorded as One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23^[5].
• Calu-3's described by source is recorded as Human tumor lines for cancer research^[6].
• Calu-3's described by source is recorded as Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium^[7].
• Calu-3's described by source is recorded as Polymorphic enzyme analysis of cultured human tumor cell lines^[8].
• Calu-3's described by source is recorded as Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins.^[9].
• Calu-3's described by source is recorded as Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl- secretion^[10].
• Calu-3's described by source is recorded as Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells^[11].
• Calu-3's described by source is recorded as Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery^[12].
• Calu-3's described by source is recorded as Established cell lines used in cystic fibrosis research^[13].
• Calu-3's described by source is recorded as Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification^[14].
• Calu-3's described by source is recorded as A gene-alteration profile of human lung cancer cell lines.^[15].
• Calu-3's described by source is recorded as A Genome-Wide Screen for Microdeletions Reveals Disruption of Polarity Complex Genes in Diverse Human Cancers^[16].
• Calu-3's described by source is recorded as The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity^[17].
• Calu-3's described by source is recorded as Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.^[18].
• Calu-3's described by source is recorded as Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring^[19].
• Calu-3's described by source is recorded as A comprehensive transcriptional portrait of human cancer cell lines^[20].
• Calu-3's described by source is recorded as The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function^[21].
• Calu-3's described by source is recorded as A mass spectrometric-derived cell surface protein atlas^[22].
• Calu-3's described by source is recorded as A landscape of pharmacogenomic interactions in cancer.^[23].
• Calu-3's described by source is recorded as Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays^[24].
• Calu-3's described by source is recorded as Evidence for thromboxane biosynthesis in established cell lines derived from human lung adenocarcinomas^[25].
• Calu-3's described by source is recorded as Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay^[26].